MDxHealth is trading 5.54% higher at $0.17, with no clear company-specific catalyst identified for the November 3 move. - The latest listed announcements concern preliminary third-quarter results and a November 12 results release, not a new announcement on November 3. - The S&P 500 and Nasdaq were higher while the Dow was lower; available evidence does not establish that market moves caused MDxHealth’s gain. - Volume or activity level is unavailable in the supplied price context.